Erweiterte Informationen für Ärzte

2019

Alayed Y. et al.        

SABR in High-Risk Prostate Cancer: Outcomes From 2 Prospective Clinical Trials With and Without Elective Nodal Irradiation

International Journal of Radiation Oncology • Biology • Physics, Volume 104, Issue 1, 36 - 41

https://www.redjournal.org/article/S0360-3016(18)33997-X/pdf

Jackson W.C. et al.

Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective Studies

International Journal of Radiation Oncology • Biology • Physics, Volume 104, Issue 4, 778 - 789

https://www.redjournal.org/article/S0360-3016(19)30612-1/pdf

Mitin   T. et al.         

SBRT for Localized Prostate Cancer: Is it Ready for Take-Off?

International Journal of Radiation Oncology • Biology • Physics, Volume 105, Issue 3, 618 - 620

https://www.redjournal.org/article/S0360-3016(19)33457-1/pdf

Zeng K.L. et al.       

Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview

Front. Oncol., 01 May 2019 | https://doi.org/10.3389/fonc.2019.00337

https://www.frontiersin.org/articles/10.3389/fonc.2019.00337/full

Al Shafa F. et al.     

A Review of Ongoing Trials of Stereotactic Ablative Radiotherapy for Oligometastatic Cancers: Where Will the Evidence Lead?

Front. Oncol., 21 June 2019 | https://doi.org/10.3389/fonc.2019.00543

https://www.frontiersin.org/articles/10.3389/fonc.2019.00543/full

Yang J. et al.           

Stereotactic ablative radiotherapy versus conventionally fractionated radiotherapy in the treatment of hepatocellular carcinoma with portal vein invasion: a retrospective analysis.

Radiat Oncol 14, 180 (2019) doi:10.1186/s13014-019-1382-1

https://ro-journal.biomedcentral.com/track/pdf/10.1186/s13014-019-1382-1

Panje C. et al.         

Radiotherapy for pelvic nodal recurrences after radical prostatectomy: patient selection in clinical practice.

Radiat Oncol 14, 177 (2019) doi:10.1186/s13014-019-1383-0

https://ro-journal.biomedcentral.com/track/pdf/10.1186/s13014-019-1383-0

Marsavo G. et al.     

Comparison of Outcomes and Toxicity Between Extreme and Moderate Radiation Therapy Hypofractionation in Localized Prostate Cancer: A Propensity Score Analysis

International Journal of Radiation Oncology*Biology*Physics Volume 105, Issue 4, 15 November 2019, Pages 735-744                

https://www.sciencedirect.com/science/article/pii/S036030161933531X

Wujanto C. et al.     

Stereotactic Body Radiotherapy for Oligometastatic Disease in Non-small Cell Lung Cancer

Front. Oncol., 12 November 2019 | https://doi.org/10.3389/fonc.2019.01219

https://www.frontiersin.org/articles/10.3389/fonc.2019.01219/full

Chiang C.-L. et al.  

Combined Stereotactic Body Radiotherapy and Checkpoint Inhibition in Unresectable Hepatocellular Carcinoma: A Potential Synergistic Treatment Strategy

Front. Oncol., 12 November 2019 | https://doi.org/10.3389/fonc.2019.01157

https://www.frontiersin.org/articles/10.3389/fonc.2019.01157/full

2018

Präzisionsbestrahlung bietet Heilungschance bei Metastasen

https://www.aerztezeitung.de/medizin/krankheiten/krebs/article/966802/krebsthera...

Die bisher umfangreichsten Prostata-SBRT-Studien belegen hervorragende Überlebensraten bei der Behandlung von Prostatakrebs mit dem Accuray CyberKnife®-System nach fünf oder weniger Sitzungen

https://www.presseportal.de/pm/61356/4071247

Dutta S.W. et al.

Evolution in the Role of Stereotactic Radiosurgery in Patients with Multiple Brain Metastases: An International Survey

IJROBP  November 1, 2018  Volume 102, Issue 3, Supplement, Page S257-58

https://www.redjournal.org/article/S0360-3016(18)32299-5/pdf

Katz A., J.Kang

Efficacy and Toxicity of Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Ten-Year Study

IJROBP  November 1, 2018  Volume 102, Issue 3, Supplement, Page S30

https://www.redjournal.org/article/S0360-3016(18)31060-5/pdf

Jingu K. et al.

Stereotactic Radiotherapy for Pulmonary Oligometastases From Colorectal Cancer: A Systematic Review and Meta-Analysis

Technol Cancer Res Treat. 2018; 17

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111389/pdf/10.1177_153303381879493...

Seiten